FDA Sets New Meeting Dates To Review Moderna, Pfizer-BioNTech EUA Requests For COVID-19 Vaccines For Children Under Five

Reuters (5/23) reports the “Food and Drug Administration set June 14-15 as the new meeting date to review Moderna Inc’s emergency authorization request for its COVID-19 vaccine for children aged 6 months to 5 years and [Pfizer-BioNTech’s] vaccine for those aged 6 months through 4 years.” In a Monday statement, the FDA said, “In light of the disclosure by Pfizer re: their data & anticipated dates for submission, we believe that we will complete review of both EUA requests within days of one another.”

FURTHER READING

CDC guide helps pediatricians prepare for COVID vaccination of children under 5